Serum Institute Of India launches the first made-in-India qHPV vaccine 'CERVAVAC'

Dr. Cyrus Poonawalla receives Lifetime Achievement Award

TIME "The Best Inventions of 2024" lists University of Oxford and the Serum Institute of India R21/Matrix-M^™.

Serum Institute of India receives positive CHMP opinion from European Medicines Agency (EMA) for SIILTIBCY^®.

Adar Poonawalla speaks to Bloomberg TV's Haslinda Amin

Serum Institute Of India in TIME Magazine's Most Influential Companies list

Serum Institute of India ships its first set of R21/Matrix-M™ Malaria Vaccine doses to Africa.

Serum Institute of India Makes Strategic Investment in IntegriMedical, India’s First Needle-Free Injection System (N-FIS) Technology.

ImmunityBio, Serum Institute of India Agree on an Exclusive Arrangement for Global Supply of Bacillus Calmette-Guerin (BCG) Across All Cancer Types.

"Vaccines are a glimmer of hope against malaria, but the battle has only just begun"

Serum Institute of India and University of Oxford Strike Landmark Licensing Agreement for Meningitis-B Vaccine

Serum Institute of India Collaborates with Univercells to bring Affordable Personalized Oncology to Masses

Bharat Biotech and Bilthoven Biologicals B.V. Announce Collaboration

New Phase 3 Trial Data Confirm the Uniquely High Efficacy and Good Safety Profile of the R21/Matrix-M™ Malaria Vaccine in African Children

Dr. Cyrus Poonawalla honoured with lifetime achievement award by Savitribai Phule Pune University

Serum Institute of India joins CEPI global network to boost production of affordable outbreak vaccines

Oxford R21/Matrix-M™ malaria vaccine receives WHO recommendation for use paving the way for global roll-out

Adar Poonawalla Receives 'Udyog Mitra' Award From Government Of Maharashtra

Adar Poonawalla awarded 'Business Leader of the Year' 2023 by the International Advertising Association (IAA) India Chapter

Cyrus Poonawalla Group appoints Keki Mistry as Strategic Advisor to all the Financial Services Ventures led by Adar Poonawalla

UK Minister visits Serum Institute Of India

Adar Poonawalla featured on the ET Grandmasters Series

International Society for Pharmaceutical Engineering (ISPE) Awards for Serum Institute Of India

R21/Matrix-M™ malaria vaccine developed by University of Oxford receives regulatory clearance for use in Ghana

Forbes India Pathbreakers: Adar Poonawalla on vaccines, strategy, and legacy

Seth Berkley CEO of Gavi visits Serum Institute Of India

Serum Institute Of India launches the first made-in-India qHPV vaccine 'CERVAVAC'

Davos 2023: Chief executive of Serum Institute of India (SII) on achieving vaccine equity

Serum Institute of India CEO Adar Poonawalla receives Dr. Patangrao Kadam Memorial Award

Department of Biotechnology announces the scientific completion of India's first qHPV vaccine ‘CERVAVAC’

Serum Institute CEO calls on Hon'ble Prime Minister Shri. Narendra Modi

U.S. Delegation visits Serum Institute of India

Johns Hopkins Bloomberg School Of Public Health Awards Highest Honour To Dr. Cyrus S Poonawalla

Adar Poonawalla receives the Business Leader of The Year award at the Economic Times Awards

Covovax now available for children in India', says Adar Poonawalla

Business Leader of the Year - All India Management Association

Adar Poonawalla, CEO, Serum Institute of India, receives the award for the Outstanding Business Leader of the Year

Dr. Cyrus Poonawalla conferred with the Padma Bhushan Award

Covid-19: Covovax gets DCGI’s EUA nod for 12-17-year-olds

SII makes available vaccines at price of 'cup of tea' to poor nations, says Cyrus Poonawalla

CEO of Serum Institute of India is finding newer frontiers to invest - Forbes India

Will continue to work towards making health equitable for all: Dr Cyrus Poonawalla

Dr. Cyrus Poonawalla to be conferred with Padma Bhushan

Adar Poonawalla - India Today Newsmakers of the Year 2021

World Health Organization Grants Emergency Use Listing for NVX-CoV2373 COVID-19 Vaccine 'COVOVAX™'

£50m funding for Poonawalla Vaccines Research Building at Oxford University

Serum Institute of India (SII) re-starts COVAX exports; passes 1 billion COVISHIELD dose milestone

Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in the Philippines

Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in Indonesia

Serum Life Sciences Ltd announces Strategic Partnership with Oxford Biomedica

Biocon Biologics and Serum Institute Life Sciences Announce Strategic Alliance

Adar Poonawalla - TIME 100 Most Influential People of 2021

SCHOTT and Serum Institute of India Announce Joint Venture for Pharmaceutical Packaging

Dr. Cyrus S. Poonawalla receives Lokmanya Tilak National Award 2021

Welcome Key Note speaker Mrs. Natasha Poonawalla at the SAYFTY Self-Care Summit

UK Secretary of State for International Trade, Liz Truss visits Serum Institute of India

Success Story of Cyrus Poonawalla: The man behind India's prestigious Serum Institute of India

India to supply 1.1 billion doses of COVID-19 vaccines to UNICEF

Serum Institute seeks approval to conduct local trial for Novavax Covid vaccine

South African regulator approves Serum Institute's Covishield days before receiving vaccine

Serum Institute’s Covishield vaccine may be recommended for international use

Covid-19 vaccination drive: After taking the first shot, here's what corona warriors said

Serum Institute Chief Adar Poonawalla takes Covid Vaccine

Inside Serum Institute - India's Covid Vaccine Hub: NDTV Exclusive

Serum Institute Of India sends out Covishield vaccine - Consignment of Covishield Vaccine arrived in Delhi, Chennai, Kolkata, Guwahati, Shillong, Ahmedabad, Hydrabad, Vijayawada, Bhubaneswar, Patna, Bengaluru, Lucknow, Chandigarh

Price of Covishield fixed at Rs 200 per dose, SII to begin shipping Covid-19 vaccine

India's Wait Over, Drug Regulator Says Covid Vaccines Cleared "110% Safe"

'Covishield' ready to roll out in coming weeks, says Serum Institute's Adar Poonawalla

Serum Institute Of India Chairman, Dr. Cyrus Poonawalla's interview with TV 18 on 30 December 2020

Oxford COVID-19 vaccine 95% effective if given 3 months apart, says SII's Adar Poonawalla

Dr. Harsh Vardhan launches Serum Institute Of India's Pneumococcal Conjugate Vaccine - Pneumosil

Serum Institute of India launches India’s first fully indigenously developed pneumococcal vaccine, 'PNEUMOSIL'

Oxford-SII's 'Covishield' likely to be Indias first COVID vaccine

First indigenous vaccine against pneumonia developed by Serum Institute to be launched next week

Serum Institute to soon produce ‘Green Vaccine’

Oxford COVID-19 vaccine: Serum Institute likely to submit final Covishield trial data within 10 days

COVID-19 vaccine: Serum Institute to make 10 crore doses each month from next year

Vaccine rollout will take two months after licensing, says Serum Institute's Poonawalla

Adar Poonawalla, CEO of Serum Institute, named 'Asian of the Year' with 6 others

PM Modi impressed with SII facility, wants vaccine out at earliest: Cyrus Poonawalla

Covid vaccine should be available for public by April 2021: Serum Institute CEO

SII’s Adar Poonawalla on Covid vaccine, pricing and rollout at Hindustan Times Leadership Summit 2020

COVISHIELD Completes Enrolment of Phase III clinical trials under partnership of ICMR and Serum Institute of India

No safety concerns related to the Covishield vaccine trial: Serum chief

Government Secures Vaccine Supplies For Half Of The Indian Population From Serum Institute And Novavax

Adar Poonawalla speaks to NDTV about the coronavirus vaccine and it's development

IAVI, Merck, and Serum Institute of India Join Forces to Develop Monoclonal Antibodies for COVID-19 and Ensure Prompt and Equitable Global Access

Coronavirus | Vaccine shot ‘painless’, say Covishield trial volunteers

Serum Institute Of India Takes A Multipronged Approach In Quest To Produce World’s First Covid-19 Vaccines

Serum Institute of India to produce up to an additional 100 million covid 19 vaccine doses for india and low and midle income countries in 2021

Adar Poonawalla CEO of Serum Institute of India, the world’s largest vaccine manufacturer, explains the timing, challenges & cost of vaccinating the world against COVID-19

Serum Institute of India begins manufacture of Codagenix's nasal COVID-19 vaccine candidate

Oxford COVID-19 vaccine: Serum Institute to start final phase of trial in India from Monday

Novavax COVID-19 vaccine: Serum Institute to start trial next month in India

Dr. Cyrus Poonawalla speaking on Vaccine Access in the Era of COVID–19

Novavax-Serum Institute to produce for 200 crore Covid-19 vaccine doses

Will resume Covid-19 vaccine trials after DCGI nod: Serum Institute

Looking forward to the Oxford covid vaccine: Serum Institute CEO

Bangladesh's Beximco signs Covid-19 vaccine deal with India's Serum Institute

Bloomberg School awards highest honor to Poonawalla and Casals

Oxford Covid-19 vaccine: Serum Institute begins clinical trial in India

ICMR helping Serum Institute in conducting clinical trials for two vaccines

Oxford COVID-19 vaccine final trials will be held in these 17 hospitals in India

Serum Institute of India to begin phase 2 trials of Oxford COVID-19 vaccine this week

Serum Institute looking for a $1 billion shot to fight covid, talks on with Blackstone, KKR and others

The World’s Best Hope for Enough Covid-19 Vaccine Comes from India

Serum Institute of India Says Covid Vaccine Likely to Be Ready by End of 2020, Final Pricing in 2 Months

Serum institute of india to produce up to 100 million covid-19 vaccine doses for india and low-and middle-income countries as early as 2021

Novavax signs COVID-19 vaccine supply deal with India’s Serum Institute

Serum Institute of India gets approval to start human trials for Oxford vaccine

Serum Institute conducting phase III clinical trial of BCG vaccine: DBT

Julia Chatterley In Conversation with CEO Mr. Adar Poonawalla

Sabina Sanghvi in Conversation with Dr. Cyrus Poonawalla

50% of our Covid vaccines will be for India, people won't have to buy them, govts will pay: Adar Poonawalla

AstraZeneca vaccine's success in early human trials, Will Begin AstraZeneca Vaccine Trial in India After Applying for Licence Next Week, Says Serum Institute

Serum Institute of India CEO: ‘We plan to make millions of doses of Covid vaccine over three months’:’

First Fully Indigenous Pneumonia Vaccine, Developed By Serum Institute, Approved

Serum Institute of India expects COVID vaccine by year-end

Serum Institute of India to supply pneumonia vaccine to low-income nations

New supply agreement between UNICEF and Serum Institute of India makes pneumococcal conjugate vaccine available at US$2.00 per dose, a 43 % reduction from the Gavi price at the start of the Advance Market Commitment

Serum Institute investing USD 100 million on potential COVID-19 vaccine

Adar Poonawalla-backed startup h2e Power acquires Swiss company Hexis AG

Global Vaccine Summit 2020

Oxford University’s COVID-19 vaccine: next steps towards broad and equitable global access

AstraZeneca & Serum Institute of India sign licensing deal for 1 billion doses of Oxford vaccine

Adar Poonawalla's vaccine: No shot in the dark

Serum Institute confident of manufacturing Covid vaccine’s 100 million doses if trials establish efficacy

To The Point with Adar Poonawalla, CEO & Owner, Serum Institute of India

Serum Institute’s Journey To Success | ET NOW Covid-19 vaccine possible by Q2 of 2022: Adar Poonawalla

Serum Institute to go for human trials for COVID-19 vaccine by year-end, says Adar Poonawala

Mylab partners with SII’s Poonawalla, APG’s Pawar to scale-up production of Covid-19 test kits

Adar Poonawalla discusses Serum Institute's progress in the global battle against COVID-19 with Shereen Bhan, CNBC-TV18

Adar Poonawalla talks with Aabha Bakaya about the success story of Serum Institute of India. Tune in to know all about the journey of the company.

The Indian vaccine king attempting to create a coronavirus cure ‘within six months’

Vaccine for COVID-19 Won’t Be Ready Before 2022, Says World’s Largest Vaccine Producer

New pneumococcal vaccine from Serum Institute of India achieves WHO prequalification

Serum Institute of India & Villoo Poonawalla Foundation to upgrade two English Medium Schools

Bill Gates confers Indian Council of Medical Research "Lifetime Achievement Medal" on Dr. Cyrus Poonawalla

Dr. Cyrus Poonawalla conferred with 'Lifetime Achievement Award’ by the Asian Business Leadership Forum

Serum Institute of India's new plant inaugurated by Hon’ble Union Health Minister Dr. Harsh Vardhan

Dr. Cyrus Poonawalla conferred with the prestigious honorary degree by the University of Oxford, U.K.

Serum Founder Wins Inaugural "Vaccine Hero" Award

Adar Poonawalla Received The CNBC Asia's Award For Corporate Social Responsibility Of The Year 2018

Adar Poonawalla is Indian of the Year in CSR Business Category | CNN-News18

PM Nominates Adar Poonawalla As Brand Ambassador For Swachh Bharat

PM Modi lauds Poonawalla’s clean city effort

Prime Minister Narendra Modi visits Serum Institute of India

Adar Poonawalla Clean City Inaugurated By CM Fadnavis